Gene expression profiling of non-small cell lung cancer
- PMID: 18440087
- PMCID: PMC2517078
- DOI: 10.1016/j.lungcan.2008.03.007
Gene expression profiling of non-small cell lung cancer
Abstract
Functional genomics has emerged over the past 10 years as a novel technology to study genetic alterations. Gene expression arrays are one genomic technique employed to discover changes in the DNA expression that occur in neoplastic transformation. Microarrays have been applied to investigating lung cancer. Specific applications include discovering novel genetic changes that occur in lung tumors. Microarrays can also be applied to improve diagnosis, staging and discover prognostic markers. The eventual goal of this technology is to discover new markers for therapy and to customize therapy based on an individual tumor genetic composition. In this review, we present the current state of gene expression array technology in its application to lung cancer.
Conflict of interest statement
Conflict of interest statement
The authors wish to disclose they have no conflict of interests.
Figures
Similar articles
-
Aspects of lung cancer gene expression profiling.Curr Opin Drug Discov Devel. 2004 May;7(3):290-303. Curr Opin Drug Discov Devel. 2004. PMID: 15216932 Review.
-
Tumor acquisition for biomarker research in lung cancer.Cancer Invest. 2014 Jul;32(6):291-8. doi: 10.3109/07357907.2014.911880. Epub 2014 May 9. Cancer Invest. 2014. PMID: 24810245 Free PMC article.
-
Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients.PLoS One. 2012;7(1):e30880. doi: 10.1371/journal.pone.0030880. Epub 2012 Jan 23. PLoS One. 2012. PMID: 22292069 Free PMC article.
-
Genome-wide analysis of survival in early-stage non-small-cell lung cancer.J Clin Oncol. 2009 Jun 1;27(16):2660-7. doi: 10.1200/JCO.2008.18.7906. Epub 2009 May 4. J Clin Oncol. 2009. PMID: 19414679 Free PMC article.
-
[An approach to individualised therapy of non-small cell lung carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors].Pneumologie. 2007 Nov;61(11):731-8. doi: 10.1055/s-2007-980130. Epub 2007 Oct 18. Pneumologie. 2007. PMID: 17948172 Review. German.
Cited by
-
Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer.Med Oncol. 2010 Jun;27(2):484-90. doi: 10.1007/s12032-009-9239-3. Epub 2009 Jun 2. Med Oncol. 2010. PMID: 19488864
-
A population-based study of outcomes in patients with surgically resected non-small cell lung cancer with anaplastic lymphoma kinase-rearranged mutations: A matched-pair study.Mol Clin Oncol. 2021 Jan;14(1):11. doi: 10.3892/mco.2020.2173. Epub 2020 Nov 19. Mol Clin Oncol. 2021. PMID: 33282286 Free PMC article.
-
Differences in the early stage gene expression profiles of lung adenocarcinoma and lung squamous cell carcinoma.Oncol Lett. 2019 Dec;18(6):6572-6582. doi: 10.3892/ol.2019.11013. Epub 2019 Oct 21. Oncol Lett. 2019. PMID: 31788115 Free PMC article.
-
Smoking-Related Gene Expression in Laser Capture-Microdissected Human Lung.Clin Cancer Res. 2009 Dec 15;15(24):7562-7570. doi: 10.1158/1078-0432.CCR-09-1694. Clin Cancer Res. 2009. PMID: 19996203 Free PMC article.
-
Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.Oncogene. 2011 Sep 1;30(35):3802-12. doi: 10.1038/onc.2011.94. Epub 2011 Apr 11. Oncogene. 2011. PMID: 21478903 Free PMC article.
References
-
- Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin. 2007;57:43–66. - PubMed
-
- Quackenbush J. Microarray analysis and tumor classification. N Engl J Med. 2006;354:2463–2472. - PubMed
-
- Watson JD. The human genome project: past, present, and future. Science. 1990;248:44–49. - PubMed
-
- Collins FS, Morgan M, Patrinos A. The Human Genome Project: lessons from large-scale biology. Science. 2003;300:286–290. - PubMed
-
- Tefferi A, Bolander ME, Ansell SM, Wieben ED, Spelsberg TC. Primer on medical genomics. Part III: Microarray experiments and data analysis. Mayo Clin Proc. 2002;77:927–940. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous